Clinical trial
The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women…
NCT00460057 · Eulji University Hospital, Other · Completed
Key facts
| NCT number | NCT00460057 |
|---|---|
| Title | The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss |
| Official title | The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women |
| Lead sponsor | Eulji University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Alendronate |
| Enrollment | 63 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Apr 13, 2007 |
| Last update posted | Aug 5, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: